Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on July 15, 2025

Veteran Aviation Leader Chris Burns Named Chief Operating Officer of Emergency Fixed-Wing Services
New leadership role reflects GMR's continued commitment to safe, patient-centered air medical services LEWISVILLE, TX, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Global Medical Response is pleased to announce the appointment of Chris Burns as …

Historic collaboration brings shipping container-based health care clinic to Jeff Davis County
LUBBOCK, TX, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Texas A…

Candela Matrix® Now Available at The Aesthetic Lab
The Aesthetic Lab in Leander, Texas, is excited to announce the Candela Matrix®, a state-of-the-art laser system, to their practice. LEANDER, TX, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- The Aesthetic Lab is excited to introduce the Candela …

Centre Welcomes New Chief Information Security Officer to Lead Secure Innovation and Customer Trust
This appointment strengthens Centre’s presence across Texas and Oklahoma and reinforces their commitment to delivering secure IT solutions with a local touch. HOUSTON, TX, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Centre Technologies, a top- …

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Gain Therapeutics Announces Proposed Public Offering
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADR Ratio Change
July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON …

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce …

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025. John …

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025. …

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced …

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload
New York, NY, July 15, 2025 (GLOBE NEWSWIRE) -- XLA Health (www.xlahealth.com) officially rebrands its HIPAA-compliant outsourcing platform designed to relieve private‐practice physicians of the everyday administrative grind. By pairing college-educated, …

Tivity Health Appoints Natasha Deckmann as CEO
NASHVILLE, Tenn., July 15, 2025 (GLOBE NEWSWIRE) -- Tivity Health, a leading provider of healthy lifestyle solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®, announced today that Natasha Deckmann, M.D., has been named Chief …

BriaCell Therapeutics Announces Pricing of $15 million Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates
PHILADELPHIA, July 15, 2025 (GLOBE NEWSWIRE) -- Renowned cardiothoracic surgeon Dr. Zachary Solomon has officially announced the launch of the Dr. Zachary Solomon Medical Tech Grant, a prestigious academic initiative aimed at cultivating future leaders in …